Saracatinib
| CAS No. | 379231-04-6 | Cat. No. | BCP01733 |
| Name | Saracatinib | ||
| Synonyms | AZD0530; AZD-0530;AZD 0530; | ||
| Formula | C27H32ClN5O5 | M. Wt | 542.03 |
| Description | Saracatinib, also known as AZD0530, is an orally available dual-specific inhibitor of Src and Abl with anti-invasive and anti-tumor activities. Src and Abl are protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. Saracatinib binds to and inhibits these tyrosine kinases and their effects on cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. | ||
| Related Products | 893428-72-3（Saracatinib difumarate） | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | Src/Bcr Abl | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.